Patients with hidradenitis suppurativa experienced
In two of the largest Phase III trials conducted in hidradenitis suppurativa (HS), Cosentyx® (secukinumab) treatment
Globe Newswire4-02-2023, 06:41
Curia Unveils Brand Refresh at CPHI WW in Milan 7-10-2024, 20:49